J Korean Diabetes.  2025 Sep;26(3):164-171. 10.4093/jkd.2025.26.3.164.

2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management

• Kim HJ

• KMID: 2572131
• DOI: http://doi.org/10.4093/jkd.2025.26.3.164

Abstract

Diabetes mellitus is a major risk factor for cardiovascular disease, and effective cardiovascular risk management is crucial for improving patient outcomes. The 2025 Clinical Practice Guidelines for Diabetes by the Korean Diabetes Association present updated recommendations for cardiovascular risk management in patients with diabetes. This review highlights key revisions in hypertension management, lipid management, and antiplatelet therapy. The most notable change is the unified blood pressure target < 130/80 mm Hg for all diabetic patients, replacing the previous risk-stratified approach. While principles for lipid management and antiplatelet therapy remain largely consistent, the guidelines continue to advocate for lifestyle modifications, statin therapy, and individualized antiplatelet use based on risk assessment.

Keyword

Cardiovascular diseases; Diabetes mellitus, type 2; Dyslipidemias; Hypertension; Platelet aggregation inhibitors; Practice guideline